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NIGERIAN STUDENT SEEKS MALARIA VACCINE
By Stephen Kemp 
University Relations Office 
University of Montana
MISSOULA—
For Tobili Sam-Yellowe, University of Montana graduate student in micro­
biology, malaria is more than a name in a textbook. Sam-Yellowe has been a 
victim of malaria, as have most of the population of her native Nigeria.
Working with Ralph Judd, assistant professor of microbiology at UM, 
Sam-Yellowe hopes to discover how the malaria parasite gains access to red 
blood cells.
If successful, Judd said, "We should have real potential for a malaria 
vaccine."
In tropical and subtropical regions malaria is still the leading cause of 
disability and death. Africa alone has an estimated 150 million cases of 
malaria each year.
Sam-Yellowe said symptoms include high fevers, chills, headaches and 
profuse sweating. The disease is especially dangerous for infants.
By discovering how the malaria parasite invades red blood cells, the 
researchers hope to find a vaccine to block the parasite's reproduction in 
the blood.
One breakthrough in their study has been the development by Judd of a
(over)
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protein analysis technique called "surface peptide mapping." This technique 
aids the researchers in identifying the proteins that allow bonding between 
malaria and red blood cells.
A malaria vaccine would have many advantages over methods currently used 
to control the disease, which include anti-malaria drugs and insecticides,
Sam-Yellowe explained that malaria parasites quickly develop tolerances 
to many drugs. These drugs sometimes have serious side effects as well, 
including yellowing of the skin and liver disorders.
Insecticides are commonly used to control mosquitoes that transmit 
malaria. But Sam-Yellowe explained that the mosquitoes are also able to 
develop a tolerance to insecticides and learn to avoid areas that have been 
sprayed.
A vaccine "would help a great deal," Sam-Yellowe said, especially toward 
"saving infants' lives."
Another problem hampering the fight against malaria is a lack of modern 
transportation and distribution systems in the rural areas of underdeveloped 
nations where malaria is endemic. Judd said an effective vaccine would have 
to be durable enough to withstand slow trips to remote villages.
"I think ours can do that," Judd said.
Both researchers are cautious, however, when estimating the benefits of 
a vaccine for this extraordinarily complex disease.
Sam-Yellowe said a vaccine "might not wipe out malaria, but it can be 
reduced. One has to set goals in a realistic fashion."
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